Global Polyacrylamide Market is Expected to Reach USD 6.91 Billion by 2019: TMR

Transparency Market Research has released a new market report titled “Polyacrylamide (Non-ionic, Cationic, Anionic, and Others) Market for Water Treatment, Petroleum, Paper Making and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019,” which observes that the polyacrylamide demand in 2012 was worth USD 3.95 billion and is expected to reach USD 6.91 billion by 2019, growing at a CAGR of 8.4% from 2013 to 2019. In terms of volume, the demand for polyacrylamide was 1,337.5 kilo tons in 2012 and is expected to cross 2,204.5 kilo tons by 2019, growing at a CAGR of 7.4% from 2013 to 2019.

Browse the full Polyacrylamide Market Report at http://www.transparencymarketresearch.com/polyacrylamide-market.html

Polyacrylamide is an important polymer having various end user applications. Key raw materials used in the production of polyacrylamide are acrylamide copolymers and catalysts. The growing environmental concerns regarding both industrial and municipal waste water as well as rapid economic growth in Asia Pacific is expected to remain the major driving force for the polyacrylamide market. Volatile raw material prices are expected to be a key challenge for market participants.

Anionic and cationic were the predominant polyacrylamide product segments, accounting for over 70% of total demand in 2012. Due to its ionic characteristics polyacrylamide is used in various waste water treatment applications. Polyacrylamide used in petroleum applications is anticipated to be the major growth market over the next few years. Growing mining activities across the globe is anticipated to increase the demand for polyacrylamide used in mining. Similar surge in demand is expected to be witnessed from shale gas extraction facilities where polyacrylamide is used as a friction reducer for economical oil recovery.

Asia Pacific accounted for 49% of the total polyacrylamide market in 2012, followed by Europe and North America. Asia Pacific is also expected to be the fastest growing regional market in terms of both polyacrylamide consumption and production. This can be attributed to the growing economies in this region. Skilled labor, cheap availability of raw materials, equipments, and land has resulted in Asia Pacific emerging as a key destination for polyacrylamide producers. Recently various manufacturers have concentrated on capacity expansion in Asia Pacific to increase their production capacities. Europe is the other major region where polyacrylamide consumption was very strong and is expected to grow in demand with a CAGR of about 6.6% in terms of volume from 2013 and 2019.

SNF, BASF SE, Kemira, PetroChina and Beijing Hengju Chemicals are some of the major participants in the polyacrylamide industry.

Polyacrylamide Market, by Product Segment:

·         Non-ionic

·         Cationic

·         Anionic

·         Others (Homopolymers, copolymers, etc.)

Polyacrylamide Market, by Application:

·         Water treatment

·         Petroleum

·         Paper making

·         Others (Chemical, bio-medical, etc.)

Polyacrylamide Market, by Region:

·         North America

·         Europe

·         Asia Pacific

·         Rest of the world (South America, Middle East and Africa)

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Global Orthobiologics Market is Expected to Reach USD 5,519.9 Million in 2019: TMR

According to a new market report published by Transparency Market Research  “Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” the global orthobiologics market was valued at USD 3,754.6 million in 2012 and is estimated to reach a market worth USD 5,519.9million in 2019at a CAGR of 5.9% from 2013 to 2019.

Orthobiologics are biomaterials used by surgeons for faster healing and quick recovery of injured muscles, bones, ligaments and tendons. It is estimated that bone and joint disorders account for approximately half of the devastating conditions in individuals with above 50 years of age. Moreover, population aged 60 years and above is expected to double by 2020 that alone represents the key driver of this market.

Browse the full Orthobiologics Market Report at http://www.transparencymarketresearch.com/orthobiologics-market.html

A rise in geriatric population, lifestyle changes coupled with growing awareness of sports and outdoor activities among the older as well as younger generation has triggered the growth of this market. Moreover, rise in obese population has concurrently led to rise in prevalence of disorders such as osteoarthritis, rheumatoid arthritis and others. In addition, technological advancements and growing adoption of bone graft substitutes are the other factors that are fuelling the growth of this market.

Viscosupplements represents the largest product segments in the orthobiologics market. Demand for viscosupplements is increasing with the rise in aging population that is more susceptible to osteoarthritic conditions. Moreover, benefits of viscosupplements over (Non-Steroidal Anti Inflammatory Drugs) NSAIDs and other pain relieving treatments has further boosted the growth of this market. Stem cell-based products are expected to show highest growth rate in the near future. Reduced costs, faster healing, quick recovery and ability to mimic autologous bone are some of the major factors anticipated to propel the growth of this market. BMP (Bone Morphogenic Proteins) which is one of the largest revenue contributor of orthobiologics in the past is expected to show a negative growth during the forecast period. 

Recall of INFUSE (Medtronic, Inc.) by the FDA due to heavy off label usage, whichis reported to have serious side effects have created negative impact on its sales. This has hampered the overall BMP market growth. Usage of synthetic bone substitutes is predicted to increase in coming years of forecast, primarily due to a host of factors such as cost effectiveness, improved outcomes and reduction in risk of disease transmission.

Spinal fusion accounted for the largest share of the market due to increase in number of spinal fusion surgeries. According to the American Academy of Orthopedic Surgeons (AAOS), approximately 465,000 spinal surgeries were performed in the U.S in 2011 and this trend is expected to grow in the future owing to rise in geriatric population. The reconstructive surgery market is poised to have thehighest growth from 2013-2019. The growth in this market is attributed to increase in hip and knee replacement surgeries. Moreover, growing awareness about the impact of joint problems and rise in sports related activities is further propelling the growth of this market.

Geographically, North America accounted for the largest share of orthobiologics market in 2012 valued at more than USD 1.5billion in 2012 followed by Europe. However, Asia-Pacific region is expected to represent the highest CAGR of over 6.4% during the forecast period owing to growing awareness about the orthopedic treatment, rising disposable income and rise in incidence of chronic arthritis.

The orthobiologics market is becoming highly lucrative for manufacturers owing to the significant growth opportunities in this field. Moreover, players are seeking to develop alternatives to the standard autograft bone due to risk of infection transmission, limited supply and to avoid lengthy hospital stay. Major players of this market include Medtronic Inc., Stryker Corporation, Sanofi, DePuySynthes, Inc., Globus Medical, Inc., Integra LifeSciences Corporation and others.

The orthobiologics market is segmented as follows:

·         Orthobiologics Market, by Products

§  Allografts

§  Machined Bones

§  Demineralized Bone Matrix (DBM)

§  Bone Morphogenic Protein (BMP)

§  Viscosupplementation

§  Stem cell therapy

·         Orthobiologics Market, by Application

§  Spinal Fusion

§  Trauma

§  Reconstructive Surgeries

·         Orthobiologics Market, by Geography

§  North America

§  Europe

§  Asia-Pacific

§  RoW

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Global Independent Lubricant Manufacturers Market is Expected to Reach USD 8.5 billion in 2019: TMR

According to a new market report published by Transparency Market Research “Independent Lubricant Manufacturers Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,”global independent lubricant manufacturers’ market was 4,523.7 kilo tons in 2012 and is expected to reach 5,432.0 kilo tons by 2019 growing at a CAGR of 2.7% from 2013 to 2019.

Rising automotive sales owing to increased applications in the automotive industry, increased regulatory support for bio-based alternatives accompanied by technical support and value added services provided by independent lubricant manufacturers’ are expected to fuel the product demand. Growing applications in the automotive and industrial sectors are likely to drive the market growth rapidly over the coming years. However, volatility in mineral oil prices and high cost of bio-based lubricants are some of the key challenges that are expected to confine the market growth. Increased research and development efforts are expected to pave way for new opportunities for the independent lubricant manufacturers worldwide.

 Browse the full Independent Lubricant Manufacturers Market Report at http://www.transparencymarketresearch.com/independent-lubricant-manufacturers.html

Independent lubricant manufacturers market is classified based on key product segments including automotive and industrial lubricants. Industrial lubricants product segment dominated the overall market in 2012. Rising automotive sales is expected to fuel the automotive lubricants demand over the forecast period. Independent lubricant manufacturers generally supply lubes to OEM car manufacturers and heavy industries namely mining, steel and agricultural industries. Growing application in the heavy industries has significantly bolstered overall market growth.

Asia Pacific dominated the global independent lubricant manufacturers market, accounting for more than 40% of the overall market share in 2012.Asia pacific was followed by North America and Europe. A significant growth in automotive sales was witnessed particularly in the U.S., which are expected to create new opportunities for the U.S. independent lubricant manufacturers. Established automotive industry in Europe comprising of leading OEM car manufacturers are some of the factors expected to fuel automotive lubricants product demand.

Some of the key independent lubricant manufacturers include Fuchs Petrolub AG, Motul, Pentosin, Liqui Moly, Unil-Opal, Carlube, Royal Purple, Amsoil, Red Line and Torco. Fuchs Petrolub AG is one of the leading independent lubricant manufacturers’ that held substantial market share in 2012 and is expected to maintain its position in the near future. The report provides an overview of these companies (global presence and distributors list) followed by their financial revenue, and detailed product portfolio.

This research analyzes and estimates the performance and market of independent lubricant manufacturers in the global scenario, providing detailed trend analysis of the market by geography and comprehensive analysis of companies that are dealing in lubricants. The report presents a thorough assessment of the strategies followed by different stakeholders by segmenting the independent lubricant manufacturers market as below:

§  Independent Lubricants Manufacturers Market: Product Segment Analysis

·         Industrial Lubricants

·         Automotive Lubricants

§  Independent Lubricants Manufacturers Market: Regional Analysis

·         North America

·         Europe

·         Asia-Pacific

·         RoW (Rest of the World)

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com          

Cord Blood Banking Services Market is Expected to Reach USD 15.2 Billion Globally in 2019: TMR

According to a new market report published by Transparency Market Research  “Cord Blood Banking Services Market (Private and Public Cord Blood Banks) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, the global cord blood banking services market was valued at USD 12.40 billion in 2012 and is expected to grow at a CAGR of 5.6% from 2013 to 2019, to reach an estimated value of USD 15.23billion in 2019.

Cord blood banking (CBB) is one of the fastest growing segment of healthcare industry. Factors such as increasing awareness, initiatives taken by governments to regulate CBB industry, increasing number of diseases that can be treated using stem cell therapy and growing concerns about developing worldwide cord blood inventory will have impact on current model of cord blood banking industry.

Browse the full Cord Blood Banking Services Market Report at http://www.transparencymarketresearch.com/cord-blood-banking-services.html

The global cord blood banking services market is segmented on the basis of type of service vendor and geography. Based on service vendor type the cord blood banking market is classified into, private cord blood banks and public cord blood banks. The market share of private cord blood banks is larger than the public cord blood banks as private banks charge the service right from the collection of the cord blood followed by storage and processing charges, spend more on advertising and incentives as compared to public banks. It is expected that the global market for private banks will reach USD 11.58 billion in 2019 with the market growing at CAGR of 1.9% from 2013 to 2019. Shift of storing cord blood in private banks to public banks is growing market share of public cord blood banks globally.

United States and some of the European countries such as U.K., and Spain are leading in cord blood banking services. Asian countries like China and India are emerging markets with higher population growth rate. UAE, Qatar and Saudi Arabia are some of the lucrative markets in RoW.

North America currently dominates the market but in future developing countries in Asia will lead the market. Growth drivers in the North American market are increasing awareness about the cord blood banking services, stem cell therapy and affordable cost. 

Some of the key market players operating in this market include Cord Blood America, Inc., NeoStem, Inc., Cryo-Cell International, Inc., Cord Blood Registry Systems, Inc. and China Cord Blood Corporation.

Global cord blood banking services market is segmented as follows:

·         Based on type of service vendor

§  Private cord blood banks

§  Public cord blood banks

·         Based on Geography

§  North America

o   United States

o   Canada

§  Europe

o   UK

o   Spain

o   France

o    Germany

o   Italy

o   Belgium

§  Asia-Pacific

o   India

o   China

o   Japan

o   Australia 

o   New Zealand

o   Philippines

§  Rest of the World

o   Brazil

o   Argentina

o   Middle Eastern Countries

o   Russia

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Global Fermentation Chemicals Market is Expected to Reach USD 60.1 Billion by 2019: TMR

Transparency Market Research has released a new market report titled “Fermentation Chemicals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019” which observes that the revenue generated by fermentation chemicals market was USD 41,567.7 million in 2012 and is expected to reach USD 60,123.9 million by 2019, growing at a CAGR of 5.4% from 2013 to 2019. The global demand for fermentation chemicals was 48,708.3 kilo tons in 2012.

Browse the full Fermentation Chemicals Market Report at http://www.transparencymarketresearch.com/fermentation-chemicals.html

Fermentation chemicals are mainly employed as process initiators in the manufacturing of wide variety of chemicals. Industrial applications market is the largest application area for fermentation chemicals followed by the food and beverages market. However, nutritional and pharmaceutical, plastics and fibers are fast growing applications of fermentation chemicals and are expected to gain a significant market share over the next six years. Fermentation chemicals are mainly used as alcohols, enzymes and organic acids. The strong global demand for alcohols is the major driver for the growing consumption of fermentation chemicals. Fermentation chemicals market is expected to grow at a CAGR of 4.3% from 2013 to 2019.

The industrial applications segment dominates the demand for fermentation chemicals and accounted for 47.1% of the global demand in 2012. Growing pharmaceuticals market in the U.S. and rising consumption of alcohol across the globe were the major growth drivers for fermentation chemicals. Another important market for fermentation chemicals is food and beverages industry, which accounted for 20.4% share of the total fermentation chemicals volume consumed in 2012. The growing demand for alcohols, enzymes and organic acids in the food and beverages, nutritional and pharmaceutical industries is expected to drive the global fermentation chemicals market in the next six years.

The global fermentation chemicals market is dominated by North America, which accounted for 33.9% of global volumes consumed in 2012. Growth of fermentation chemicals market in North America is principally driven by the rising consumption from the pharmaceutical and food and beverages industry in the U.S. North America was followed by Asia Pacific with 27.1% share in total volume consumption. The saturation in the North American and European market has led the major player players to focus on the highly attractive Asia Pacific market. The key players in the fermentation chemicals market are Ajinomoto Company Incorporation, BASF SE, Dow Chemical Company, Novozymes A/S, Cargill Incorporation, Evonik Industries and Du Pont Danisco A/S among others.

Fermentation Chemicals Market - Product Segment Analysis:

·         Alcohols

·         Enzymes

·         Organic Acids

·         Others

Fermentation Chemicals Market - Application Segment Analysis:

·         Industrial Applications

·         Food and Beverages

·         Nutritional and Pharmaceutical

·         Plastics and Fibers

·         Others

Fermentation Chemicals Market - Regional Analysis:

·         North America

·         Europe

·         Asia Pacific

·         Rest of the world

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Equine Healthcare Market is Expected to Reach USD24.5Billion Globally in 2019: TMR

According to a new market report published by Transparency Market Research “Equine Healthcare Market (Diagnostic Products, Therapeutic Products and Supplement Products) -Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”the global equine healthcaremarket was valuedat USD 26.6 billionin 2012and is expected to decline at a CAGR of -1.2% from 2013 to 2019, to reach an estimated value of USD 24.5 billion in 2019.

Browse the full Equine Healthcare Market Report at http://www.transparencymarketresearch.com/equine-healthcare-market.html

The equestrian industry results in a substantially high economic impact as a result of one of the industry’s primary activity - horse racing and betting; horse racing and betting comprises ~20% share of the global betting/gambling market. The equestrian industry thus generates a multiplier effect resulting into turnover of over ~USD 500 billion per year. Due to the ‘trickle-down effect’ of flow of the economic impact of the overall equestrian industry, multiple support or secondary markets exist and sustain; the equine healthcare market is among such support or secondary markets. As the base of existence of the equestrian industry is the population/number of horses worldwide, any change in the equine population impacts the equestrian industry and the support or secondary markets such as the equine healthcare market. Many experts and corroborating statistical data reveals that the global equine population is expected to decline over the years till 2019; consequentially, the equine healthcare market too is expected to decline by 1.2% over six years, from 2013 to 2019, to reach an estimated value of USD 24,527.8 million in 2019.

Equine healthcare market comprises of various ‘product market segments’ in context of various products used for treatment of equine-specific healthcare conditions, diagnosis of equine-specific healthcare conditions and also supplements and protection products used for upkeep and maintenance of a horse.Thus the three prime segments of the equine healthcare market are equine diagnostic products, equine therapeutic products and equine supplement products.

In context of equine (pregnancy and gestation) diagnostic products, there are two key categories of products used namely UltraSound devices and equine urine test kits. Of the two categories, equine urine test kits are affordable and easy-to-use and interpret the results and also help overcome a prime limitation of UltraSound devices i.e. the kits are non-invasive in nature. Thus, we expect equine urine test kits to be increasingly preferred by the veterinarians and the end-users, going forward. Also, the equine urine test kit is a unique product to the equine species and cannot be substituted by the urine test kits for humans. Therefore, we estimate the urine test kits market to be a niche opportunity that is likely to be encashed by newer entrants thus expanding the market and driving growth of the equine diagnostic products market.

In terms of geographical marketsof the equine healthcare market, the Asia-Pacific region is touted to be the ‘next growth story’. A constituent of Asia-Pacific namely the Australian market is among the leading ‘horse producing/breeding’ countries. Additionally, China is expanding capacity and investing in horse racing and betting by importing quality breeds from other countries. China is thus intent on maintaining particularly race-horse breeds. As race-horses require additional and specific supplement and protection products, therapeutic and also diagnostic products, sales of all these products is thus expected to be high in the Asia-Pacific market. Therefore the afore-mentioned factors are likely to drive growth of the Asia-Pacific market.

Theglobal equine healthcaremarket is segmented as follows:

Equine Diagnostic Products Market, by Type

·        Equine Pregnancy and Gestation Diagnostic Products Market

·        Equine Genotype Analysis Products Market

Equine Therapeutics Product Market, by Type

·        Equine Vaccines Market

·        Equine Antibacterials Market

·        Equine Antivirals Market

·        Equine Antiprotozoals/Dewormers Market

·        Equine Dopamine Agonists Market

·        Equine Anti-inflammatory Drugs Market

·        Equine Laxatives Market

Equine Supplement Products Market, by Type

·        Equine Performance Supplement Market

·        Equine Protection Products Market

·        Equine Prosthetics Market

Equine HealthcareMarket, by Geography

·        North America

·        Europe

·        Asia-Pacific

·        Rest of World (RoW)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Wearable Medical Devices Market is Expected to Reach USD 5.8 Billion Globally in 2019: TMR

According to a new market report published by Transparency Market Research “Wearable Medical Devices Market(Heart Rate Monitors, Activity Monitors, ECG, Pulse Oximeters, EEG, EMG, Glucose/Insulin Management, Pain Management, Wearable Respiratory Therapy) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,”the global market for wearable medical devices was valued at USD 2.0 billion in 2012 and is expected to reach a value of USD 5.8 billion in 2019, growing at a CAGR of 16.4% from 2013 to 2019.

Browse the full Wearable Medical Devices Market Report at http://www.transparencymarketresearch.com/wearable-medical-devices.html

Wearable medical devices defined in the strictest sense are devices with sensors attached to the body that detect and monitor changes in body signatures of various areas and organs. This report focuses on the various segments of wearable devices currently available in the market and also predicts the introduction of several innovative devices in the future.Healthcare segment forms a major part of the wearable technology market since the innovation of several applications in this area in the last two decades. 

The meek wrist watch that was used to monitor only heart rate in the last decade has today been transformed into a powerful gadget that can today store vast quantities of data on patient information such as SPO2, heart rate, temperature, blood pressure and water content in the body among several other intelligent diagnostic parameters. Smart phones have made an extremely impressive expansion in terms of applications and can now perform actual diagnostic tests such as the Apple iPhone Glucose test.

The market is highly dynamic and trendy in nature with a heavy importance given to aesthetics and ergonomics of devices. Over 65% of technologies are wrist held devices shaped like watches and the rest include wearability on other areas of the body such as arms, torso and waist. Along with the aesthetics several other features for durability of the device are included such as to make them waterproof and weatherproof. The latest in developments in telecommunication, wireless connectivity and user interface has been applied to these devices to make them more user friendly and keep them easy to interpret even by normal people in order to map their improvement in performance.

In 2013, Google Inc. introduced the Google Glass, a wearable eyewear that is highly dynamic and has varied applications throughout all industries. The success of the device at a consumer level is yet to be decided, but the technology has proven to be a boon to hospitals and the medical community for telemedicine and teleradiology. Philips has already launched an ambitious project to equip hospitals with the tech along with its proprietary hospital apps and devices in order to gain a better coverage and increase use of its devices. The device can connect into Philips Intellivue Solutions to quickly transfer crucial information of patient vital signs into the glass where it can be stored inside a 16 GB drive for multiple use, transfer it to another doctor, share it over several continents with a specialized medical expert.

The market is expected to remain in strong growth phase as purchase power expands for people in emerging countries of Asia-Pacific and Rest of the World. North America remains in lead for 2012 with a market share of 44%. In terms of competition, the market is highly fragmented and there is no clear leader in terms of revenue considering the whole market. Some of the major market players in the global medical sensors market include Nike, Fitbit, Jawbone, Phyode, Basis Science, Corventis, LifeWatch, Intelesens, Philips, Omron, Zephyr Technology Corporation, Polar Electro, Withings, Sotera Wireless and many more companies each with their own innovative technologies. All in all, this report mentions over 100 companies with a brief emphasis on their technologies.

The global wearable medical devices market is categorized into the following segments:

§  Wearable Medical Devices Market, by Product Types

o   Wearable TherapeuticMedical Devices

o   Wearable DiagnosticMedical Devices

§  Wearable Diagnostic Medical Devices Market, by Product Types

o   Vital Signs Monitors

o   Fetal & Obstetric Devices

o   Neuromonitoring Devices

§  Wearable Therapeutic Medical Devices Market, by Product Types

o   Pain Management

o   Glucose/Insulin Monitoring

o   Respiratory Therapy Devices

§  Wearable Therapeutic Medical Devices Market, by Application

o   Sports and Fitness

o   Remote Patient Monitoring

o   Home Healthcare

§  Wearable Medical Devices Market, by Geography

o   North America

o   Europe

o   Asia-Pacific

o   Rest of the World (RoW)

Browse the full Wearable Medical Devices Market Report at http://www.transparencymarketresearch.com/wearable-medical-devices.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/